Antimicrobial resistance

Tiny germs can change to stay safe.

Some medicines fight these germs. These medicines help people, animals, and plants.

Sometimes, germs learn to hide from the medicine. They can even share secrets on how to hide. This makes the medicine stop working. It can make it hard to get well. We must use medicine the right way. This helps keep everyone safe and strong.

Tiny germs can change to stay safe from medicine.

These medicines are called antimicrobials. They fight germs like bacteria, viruses, fungi, and parasites.

When germs change, they become resistant. This means the medicine no longer works. Resistance is a trait of the germ, not the person.

Germs change in a few ways. Sometimes, a tiny change happens when they make copies of themselves. We call this a mutation. Other times, germs share secrets. They pass pieces of DNA to each other. This is called horizontal gene transfer. This helps the resistance spread fast.

Human actions make this happen faster. Using too much medicine or using it the wrong way helps germs adapt. This is a big problem for the world. It makes common sicknesses harder to treat. It also makes medical care more costly. Experts say we must work together to stop it. We can use medicine carefully and keep things clean. This helps keep people, animals, and the land healthy.

Antimicrobial resistance, or AMR, is a major global health threat. It happens when tiny living things called microbes change to protect themselves from medicines. These medicines, known as antimicrobials, are used to treat infections in humans, animals, and plants. AMR affects many types of microbes, including bacteria, viruses, parasites, and fungi. When bacteria become resistant to the drugs meant to kill them, it is called antibiotic resistance. This makes common illnesses much harder to treat.

There are a few ways this resistance works. Sometimes, a tiny change called a mutation happens when a microbe makes copies of itself. These changes can help an individual microbe survive medicine. Other times, microbes use horizontal gene transfer to share resistance. This is like passing a secret instruction manual to a neighbor. They can do this through processes called conjugation, transduction, or transformation. This allows resistance to spread quickly between different microbes.

Human activities often speed up this natural process. Using too many antimicrobials or using them the wrong way is a primary driver. For example, up to 46 million antibiotic prescriptions in a year may be unnecessary. When people stop taking medicine too early, the strongest microbes might stay in the body. They can then multiply and spread. This misuse happens in both medicine and agriculture.

The scale of this problem is very large. In 2019, bacterial AMR was directly responsible for 1.27 million deaths globally. It also contributed to nearly 5 million total deaths that year. One in five people who died from AMR were children under five. The World Health Organization warns that deaths could reach 10 million every year by 2050. Different areas face different levels of risk. For instance, Sub-Saharan Africa has a rate of 23.7 deaths per 100,000 people.

To fight AMR, experts use a method called the One Health approach. This idea shows that the health of people, animals, and the environment are all connected. We must work together across many different groups. This includes doctors, farmers, and researchers. We can help by using the right dose of medicine and keeping things clean. Improving hygiene and finding new vaccines are also vital steps.

Antimicrobial resistance, or AMR, is a biological phenomenon where microbes evolve mechanisms to protect themselves from drugs. These medicines, known as antimicrobials, are essential for treating infections in humans, animals, and plants. AMR is an umbrella term covering several specific types of resistance. It includes antibiotic resistance in bacteria, antiviral resistance in viruses, antiparasitic resistance in parasites, and antifungal resistance in fungi.

When microbes become resistant, the drugs that once killed them become ineffective. This makes common infections much harder to manage and increases the risk of severe illness or death.

Resistance occurs through several distinct biological pathways. One common way is through spontaneous genetic mutation. During cell division, a microbe may experience a random change in its DNA. If this mutation allows the microbe to survive exposure to a drug, it will continue to multiply. Another method is horizontal gene transfer, where microbes share resistance genes with one another. They can do this through conjugation, transduction, or transformation.

This allows resistance to spread rapidly, even between different species of bacteria. Resistance can also be categorized as microbiological or clinical. Microbiological resistance involves specific genes that block a drug's mechanism. Clinical resistance is observed when a treatment fails to work during a patient's therapy.

While resistance can occur naturally over time, human activities greatly accelerate the process. The misuse and overuse of antimicrobials are primary drivers of this trend. In some regions, up to one in three antibiotic prescriptions may be unnecessary. For example, approximately 46 million out of 154 million annual antibiotic prescriptions are considered inappropriate. Overprescribing in both human medicine and agriculture increases the selective pressure on microbes. This pressure favors the survival of resistant strains.

Additionally, when patients stop taking their medication early, the most resilient microbes may survive and reproduce.

Scientists use specific protocols to identify these resistant microbes in a laboratory. One common method is the Kirby-Bauer disk diffusion susceptibility test. In this test, bacteria are spread onto a solid medium in a Petri dish. Paper disks containing different antibiotics are placed on the surface.

If the bacteria are not resistant, they will not grow near the disks, creating clear rings. If the bacteria are resistant, they will continue to grow right up to the edge of the disk. Microbes that can resist many different types of drugs are called multidrug-resistant, or MDR. They are sometimes referred to as superbugs.

The global impact of AMR is a major public health crisis. In 2019, bacterial AMR was directly responsible for 1.27 million deaths worldwide. It also contributed to nearly 4.95 million total deaths that year. One in five people who died due to AMR were children under the age of five. The World Health Organization warns that annual deaths could reach 10 million by the year 2050.

The burden varies by region. Sub-Saharan Africa sees 23.7 deaths per 100,000 people, while North Africa and the Middle East see 11.2 deaths per 100,000.

Addressing this issue requires a complex, multi-sectoral strategy known as the One Health approach. This framework recognizes that human health, animal health, and environmental health are interconnected. Resistance can spread through agricultural runoff, wastewater, or the improper disposal of medicine. These substances enter soil and water systems, affecting the entire ecosystem. To fight AMR, we must coordinate efforts across governments, farmers, and healthcare workers. This includes improving hygiene, developing new vaccines, and ensuring better access to necessary medicines in developing nations.

Without significant action, the world may enter a "post-antibiotic era." In this era, many common infections could become untreatable. Even vital medical procedures like surgery, organ transplants, and cancer treatments could become much riskier. Because new antibiotics are not being developed fast enough, the gap between infection and treatment is growing. Managing AMR is not just a medical challenge, but a global necessity for food security and economic stability.